VVOS · ISSUER CIK 1716166
Vivos Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Vivos Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 202617:04 | Jun 30, 2026 | VVOS | Chief Executive Officer, Director | J · OtherLate 80d | $0.58 | +85,910 | 85,910 | New | $50K | ||
| Aug 26, 202616:10 | Jul 31, 2026 | VVOS | Principal Accounting Officer | A · GrantLate 26d | $0.41 | +250,000 | 250,080 | +312500% | $103K |